Monday, September 17, 2018
Scripps Study Finds Opioid Users Could Benefit from Meth-Relapse Prevention Strategy

New research raises the possibility that a wider group of people battling substance abuse disorders may benefit from a Scripps Research-developed relapse-prevention compound than previously thought. The research, published recently in the journal Learning and Memory, shows that the compound appears to be effective even if multiple drugs of abuse are involved, such as methamphetamine in combination with either opioids or nicotine. ..

Read More
Tuesday, April 10, 2018
Scripps Florida Researchers Awarded $2.875 Million to Destroy Common Form of Leukemia

Christoph Rader, Ph.D., associate professor at the Florida campus of The Scripps Research Institute, has been awarded a $2.875 million, five-year grant from the National Cancer Institute to develop unique antibody-drug conjugates engineered to eradicate one of the most common forms of leukemia, chronic lymphocytic leukemia. Doctors diagnose more than 20,000 people a year in the United States with chronic lymphocytic leukemia. ..

Read More
Tuesday, March 24, 2015
New FAU, Scripps Florida, Max Planck Collaboration Aims to Accelerate Innovation, Drug Discovery and Technology Development

Unique Research and Education Collaboration Shows that ‘The Whole is Greater Than the Sum of its Parts’ ..

Read More
Tuesday, January 13, 2015
Scripps Florida Scientists Develop Novel Platform for Treatment of Breast, Pancreatic Cancer

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have identified a novel synthetic compound that sharply inhibits the activity of a protein that plays an important role in in the progression of breast and pancreatic cancers. ..

Read More
Monday, December 22, 2014
Scripps Research Institute Scientists Uncover New, Fundamental Mechanism for How Resveratrol Provides Health Benefits

Scientists at The Scripps Research Institute (TSRI) have found that resveratrol, the red-wine ingredient once touted as an elixir of youth, powerfully activates an evolutionarily ancient stress response in human cells. The finding should dispel much of the mystery and controversy about how resveratrol really works. ..

Read More
Tuesday, October 28, 2014
Scripps Florida Scientists Uncover Major Factor in Development of Huntington’s Disease

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have uncovered a major contributor to Huntington’s disease, a devastating progressive neurological condition that produces involuntary movements, emotional disturbance and cognitive impairment. ..

Read More
Monday, October 27, 2014
New Clinical Trial Data: Scripps Research Institute MS Drug Candidate Also Shows Promise for Ulcerative Colitis

Positive new clinical data were released today on a drug candidate for ulcerative colitis that was first discovered and synthesized at The Scripps Research Institute (TSRI). ..

Read More
Monday, September 22, 2014
Scripps Research Institute Scientists Awarded $7.9 Million to Develop Artificial Immune System

Scientists from both campuses of The Scripps Research Institute (TSRI) have been awarded a total of $7.9 million from the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense.  ..

Read More
Thursday, September 04, 2014
Scripps Team Identifies Important Regulators of Immune Cell Response

In a collaborative study, scientists from the Florida campus of The Scripps Research Institute (TSRI) and the La Jolla Institute for Allergy and Immunology have developed a more effective method to determine how immune cells called T cells differentiate into specialized types of cells that help eradicate infected cells and assist other immune cells during infection. ..

Read More
Tuesday, September 02, 2014
Scripps Florida Scientists Make Diseased Cells Synthesize Their Own Drug

In a new study that could ultimately lead to many new medicines, scientists from the Florida campus of The Scripps Research Institute (TSRI) have adapted a chemical approach to turn diseased cells into unique manufacturing sites for molecules that can treat a form of muscular dystrophy. ..

Read More